Exchange: NASDAQ·Updated 05:54 PM EDT
GNPX logo

GNPX Genprex Inc

$3.62
$0.03
(0.87%)
Today
Closed $3.48
$0.14
(4.02%)
After Hours
Reported EarningsAug 28
Mkt Cap$2.83M
Vol116,762.00

About GNPX

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner on April 1, 2009 and is headquartered in Austin, TX.
55

Bullish Sentiment

How do you feel about GNPX?

Advertisement|Remove ads.